Are all ADHD medications created equal? Exploring the differences that enable evening dosing
Gregory W Mattingly1,2,3, Julie A Carbray4, Perry Roy5
1Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
Postgraduate Medicine
|June 21, 2024
Summary
New delayed-release and extended-release methylphenidate (DR/ER-MPH) offers a novel evening dosing option for attention-deficit/hyperactivity disorder (ADHD). This review examines its characteristics and clinical utility for patients with ADHD.
Area of Science:
- Pharmacology and Psychiatry
- Neuroscience and Behavioral Science
Background:
- Attention-deficit/hyperactivity disorder (ADHD) treatment involves over 30 stimulant medications, primarily amphetamine or methylphenidate variants.
- Diverse formulations and delivery systems create unique pharmacokinetic and clinical profiles, enabling personalized ADHD treatment.
- Traditionally, long-acting stimulant options required morning dosing.
Purpose of the Study:
- To evaluate the characteristics and clinical utility of delayed-release and extended-release methylphenidate (DR/ER-MPH).
- To provide practical guidance for clinicians on using DR/ER-MPH in pediatric and adult ADHD populations.
- To contextualize DR/ER-MPH within the broader landscape of ADHD pharmacotherapy.
Main Methods:
- Review of available clinical data.
- Analysis of real-world evidence and emerging research.
- Incorporation of expert clinical experience.
Main Results:
- DR/ER-MPH represents the first long-acting stimulant designed for evening administration.
- This formulation provides delayed clinical effects upon morning awakening, a paradigm shift in stimulant therapy.
- The unique pharmacokinetic profile of DR/ER-MPH warrants clinical consideration for tailored ADHD management.
Conclusions:
- DR/ER-MPH offers a novel therapeutic option for managing ADHD, distinct from traditional morning-dosed stimulants.
- Understanding its characteristics is crucial for optimizing treatment strategies in children, adolescents, and adults.
- Further real-world data and clinical experience will refine the application of this innovative ADHD medication.
Keywords:
Amphetaminedelayed-release and extended-release methylphenidatedosingdurationextended-releaselong-actingmethylphenidatepharmacokineticspharmacotherapyMore Related Videos
Related Concept Videos
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
57
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
57
01:30Attention-Deficit/Hyperactivity Disorder
55
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
55
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
168
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
168
01:19Management of Insomnia
244
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
244
01:23Antidepressant Drugs: MAOIs and Other Agents
220
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
220
01:21Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K